Douglas Hom (Doug Hom)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Systemic Lupus Erythematosus

Bariatric Surgery

Ankylosing Spondylitis

Top Venues

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

David C Rees, Yurdanur Kilinc, Selma Unal, Carlton D Dampier, Betty S Pace, Banu Kaya, Sara Trompeter, Isaac Odame, Johnny N Mahlangu, Sule Unal, Julie Brent, Regine Grosse, Beng R Fuh, Baba Psalm Duniya Inusa, Ariel Koren, Goksel Leblebisatan, Carina Levin, Elizabeth McNamara, Karin Meiser, Douglas Hom, Stephen J Oliver
A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia. Blood 139 (17) (2022)
Daniel James Rader, Eleftheria Maratos-Flier, Amanda Nguyen, Douglas Hom, Michael Ferriere, Yifang Li, Jill Kompa, Miljen Martic, Markus Hinder, Craig T Basson, David Yowe, John L Diener, Allison B Goldfine, null null
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia. The Journal of clinical endocrinology and metabolism (2021)